We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+10.15%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.23B
AUM Growth
+$348M
Cap. Flow
+$172M
Cap. Flow %
7.72%
Top 10 Hldgs %
19.36%
Holding
1,755
New
109
Increased
939
Reduced
649
Closed
58

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$14.5M
2
AMGN icon
Amgen
AMGN
+$11.6M
3
ABBV icon
AbbVie
ABBV
+$10.2M
4
CELG
Celgene Corp
CELG
+$8.88M
5
BIIB icon
Biogen
BIIB
+$7.99M

Sector Composition

Rank Sector Weight
1 Healthcare 24.35%
2 Technology 12.32%
3 Financials 9.33%
4 Industrials 8.44%
5 Consumer Discretionary 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
1
Gilead Sciences
GILD
$162B
$78.2M 3.51%
1,041,206
+207,621
+25% +$14.5M
AMGN icon
2
Amgen
AMGN
$198B
$58.5M 2.62%
512,520
+102,106
+25% +$11.6M
ABBV icon
3
AbbVie
ABBV
$448B
$52.4M 2.35%
992,191
+208,339
+27% +$10.2M
CELG
4
DELISTED
Celgene Corp
CELG
$47.3M 2.12%
559,360
+112,222
+25% +$8.88M
BIIB icon
5
Biogen
BIIB
$29.2B
$44.7M 2%
159,865
+30,890
+24% +$7.99M
AAPL icon
6
Apple
AAPL
$4.79T
$41.8M 1.87%
2,083,480
+234,080
+13% +$4.42M
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.17T
$33.5M 1.5%
1,201,647
+182,843
+18% +$4.62M
XOM icon
8
ExxonMobil
XOM
$640B
$27.9M 1.25%
275,966
-16,727
-6% -$1.55M
MSFT icon
9
Microsoft
MSFT
$2.9T
$25.3M 1.13%
675,322
+74,067
+12% +$2.69M
AMZN icon
10
Amazon
AMZN
$2.63T
$22.5M 1.01%
1,127,240
+180,260
+19% +$3.24M
JNJ icon
11
Johnson & Johnson
JNJ
$615B
$20.2M 0.91%
220,565
+13,326
+6% +$1.23M
ALXN
12
DELISTED
Alexion Pharmaceuticals
ALXN
$17.7M 0.79%
133,014
+26,431
+25% +$3.17M
CVX icon
13
Chevron
CVX
$384B
$15.5M 0.7%
124,319
-8,823
-7% -$1.07M
PFE icon
14
Pfizer
PFE
$141B
$15.3M 0.68%
524,816
+20,962
+4% +$610K
REGN icon
15
Regeneron Pharmaceuticals
REGN
$68.3B
$14.8M 0.66%
53,818
+9,844
+22% +$2.83M
META icon
16
Meta Platforms (Facebook)
META
$1.59T
$13.3M 0.6%
243,325
+75,032
+45% +$3.77M
CMCSA icon
17
Comcast
CMCSA
$84B
$12M 0.54%
463,690
+70,522
+18% +$1.7M
VRTX icon
18
Vertex Pharmaceuticals
VRTX
$120B
$11.8M 0.53%
158,336
+31,950
+25% +$2.22M
INTC icon
19
Intel
INTC
$516B
$11.5M 0.51%
441,225
+34,037
+8% +$823K
MRK icon
20
Merck
MRK
$315B
$11.4M 0.51%
238,286
+15,536
+7% +$710K
EBAY icon
21
eBay
EBAY
$49.3B
$11.1M 0.5%
479,942
+110,624
+30% +$2.45M
GE icon
22
GE Aerospace
GE
$354B
$10.5M 0.47%
78,463
+11,749
+18% +$1.48M
JPM icon
23
JPMorgan Chase
JPM
$926B
$10.4M 0.47%
177,604
-22,412
-11% -$1.23M
QCOM icon
24
Qualcomm
QCOM
$185B
$10.4M 0.47%
139,876
+14,846
+12% +$1.05M
BKNG icon
25
Booking.com
BKNG
$138B
$10.3M 0.46%
221,925
+43,975
+25% +$1.96M

Similar funds

Profund Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, Profund Advisors held 1,755 positions worth $2.23B, up 18% from $1.88B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Profund Advisors deployed $172M of net new capital in Q4 2013, opening 109 new positions and adding to 939 existing holdings. Its largest new stake was Ambev: 287,712 shares worth $2.12M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was ARM HOLDINGS PLC ADS, an estimated $2.18M trimmed.

  • Profund Advisors's largest Q4 2013 buy was Ambev: 287,712 shares worth $2.12M.
  • Profund Advisors added most to Gilead Sciences in Q4 2013, an estimated $14.5M increase.
  • Profund Advisors's biggest Q4 2013 reduction was ARM HOLDINGS PLC ADS, cutting an estimated $2.18M.
  • Profund Advisors fully exited COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH in Q4 2013, selling an estimated $2.1M.
  • Profund Advisors's ten largest holdings make up 19% of its $2.23B portfolio in Q4 2013.
  • Profund Advisors opened 109 new positions and closed 58 in Q4 2013.
  • Profund Advisors's portfolio value rose 18% quarter-over-quarter to $2.23B.

Based on Profund Advisors's 13F filing for Q4 2013, filed 4 Feb 2014.